Could umbilical cord stem cells help failing hearts?

NCT ID NCT07265349

Recruiting now Disease control Sponsor: Tasly Pharmaceutical Group Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether injecting stem cells from umbilical cords into the heart during bypass surgery can help repair heart muscle and improve function in people with chronic heart failure. About 51 adults with weak hearts (ejection fraction 40% or less) will take part. The goal is to see if the treatment is safe and can improve the heart's pumping ability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiomyopathy congestive heart failure dilated cardiomyopathy heart failure myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEART FAILURE CHRONIC ISCHEMIC CARDIOMYOPATHY CORONARY ARTERY BYPASS GRAFTING (CABG)

Contacts and locations

Locations

Changhai Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, China
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, 20000, China
Shanghai Chest Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, China
Shanghai General Hospital
RECRUITING

Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.